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Abstract
Opioid Use Disorder (OUD) is a substance use disorder that characterizes a dependence
on and an addiction to opioids. Opioids attack the prefrontal cortex, the dopaminergic reward
system, and the hypothalamic-pituitary-adrenal (HPA) axis which is responsible for the body’s
stress response. Opioids constantly shift one’s “set point” to the point where normal actions that
cause joy and excitement no longer cause those feelings, resulting in craving and dependence.
The opioid epidemic is currently ravaging the United States and has disproportionately affected
Native American populations specifically in the rural areas (Tipps, et.al, 2018). The current
methods for addressing OUD include medicine and is more formally called medical assisted
treatment (MAT). Different agonist and antagonist medicines are utilized, including methadone,
buprenorphine, and naltrexone, and occasionally Patient Centered Care (PCC) is an aspect of
OUD treatment. This treatment style leaves gaps in the patients’ personal development, mental
health, and confidence and self-esteem building. Therefore, this proposal will attempt to combine
culturally holistic methods with MAT in order to fill those gaps and address aspects relating to
the patient’s internal development post-addiction. Using a range of tests ranging from sobriety
retention rate, to familial re-integration using the Family Environmental Scale (FES), to urinary
cortisol levels, and finally neuroimaging using fMRI and EEG on two groups of OUD patients
with Native American or Mexican heritage (n=45). Culturally holistic methods will be a
combination of Native American and Mexican indigenous healing methods. The first group will
only receive MAT while the second group will receive both MAT and culturally holistic
methods, in order to compare the effects of this additional healing approach. We expect that the
second group will consistently outperform group one on all tests due to the increased attention to
their personal development and attention to mental health.
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Introduction & Background
Widespread Drug/Opioid Abuse in the US
The opioid epidemic stretches across the United States and has devastating impacts on
individuals and communities alike. The beginning of the opioid crisis began in the 1990’s
through prescription pain medications, with deaths increasing since about 1999 (CDC, 19982008). In 2018, the death toll from opioid overdose increased to 46,802, which accounts for
69.5% of all drug overdose deaths, according to the CDC. Shortly following that period the
problem of heroin addiction has arisen, easily as dangerous and accessible as the pill form, and
finally the use of synthetic opioids such as fentanyl, which even in the smallest doses is deadly.
Prescription medications are often dosed in pill form and are given to treat moderate to severe
pain following surgery, or sometimes for pain associated with cancer. Pills can be easily misused
and often are. Commonplace names for popular opiates are OxyContin, Vicodin, and Percocet’s.
In contrast, a cheaper but as effective drug is heroin, which is similarly produced from morphine
found in poppy flowers, which can be snorted or smoked. In 2017-2018 there has been a
decrease in heroine deaths by 4% (CDC, 2020), which may be due to the shift from a heroinebased market to a fentanyl-based market. Fentanyl is the number two most dangerous opiate –
after elephant tranquilizers – and poses the greatest threat today (Dana Point Rehab, 2019).
Fentanyl is often found in other substances; sometimes it is cut with cocaine or other powders to
make the sale cheaper for the dealer and the high more potent.
This epidemic has reached communities of all socioeconomic statuses, races, genders,
and ethnicities. The level of opioid use is spread out across large metropolitan areas, small
metropolitan areas, and nonmetropolitan areas nearly equally (figure 1). Since the drug is
available at many different sources and prices, there is not a bar in who can access it. Depending
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on the density and urbanicity of the place, the access to different types of opioids may differ. For
example, the CDC reported that the death rates related to natural and semisynthetic opioids were
the highest in nonmetropolitan areas, while heroin related deaths were the lowest.

Figure 1. Trends in prevalence of past-year illicit drug use disorder among persons reporting past-year illicit
drug use, by sex and residential area† — National Survey of Drug Use and Health, United States, 2003–2014

Neuroscience of Opioid Addiction
Opioids are a pain-relieving drug that is derived from opium-containing poppy seeds.
Opioids directly impact the brain and the normal function of neurons and neurotransmitters. One
of the most famous (or infamous) neurotransmitters is dopamine, in which many addictive
substances can influence quite heavily. In order for the neurons to complete their job of wiring
messages throughout the brain, or sending neurotransmitters across the synapse, the postsynaptic
neuron may be excited, inhibited, or altered in some other biochemical way (Loue, Sana, 2003).
This release of rewarding neurotransmitters is the first phase in non-medical opioid users, and
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the second phase begins when the dopaminergic or reward system become hyperactive, and the
prefrontal cortex is impaired, which is most often shown by heightened impulsivity. Finally, the
third phase is what essentially causes the addiction, meaning an impaired neuronal system and
change in the reward system that causes an extremely intense need for the drug (Brown, 2020).
More specifically, the prefrontal cortex and its impulses are compromised and therefore
so are accompanying functions such as impulse control, and basic cognitive and emotional
functioning. Opioids in turn attach to mu receptors which has the effect of releasing more
dopamine, and in contrast opioids also activate the kappa receptors, which actually reduces
dopamine release and causes feelings of dissatisfaction, prompting users to take more to reverse
those feelings. The hypothalamic-pituitary-adrenal axis, which mediates the body’s response to
stress, is also severely disrupted by opioid use (Brown, 2020). Another circuit that is impacted is
the mesolimbic or midbrain reward system. Signals are released from the ventral tegmental area,
which releases dopamine to the nucleus accumbens. Our brains in turn remember these feelings,
also known as conditioned associations, further leading to cravings.
Some of the most visible symptoms of someone who is addicted to opioids or who is
experiencing withdrawal include slurred speech, impaired concentration, and pinpoint pupils, for
example. This is a result of opioids attaching to those mu receptors in the locus cerelus, in which
neurons produce and distribute noradrenaline which stimulates alertness, wakefulness, blood
pressure, and other functions. Opioids prevent the release of noradrenaline and therefore the user
is left with sleepiness, low blood pressure, and pressured breathing as well (Kosten, 2002). What
then begins to happen is that the “set point” is being constantly changed; noradrenaline will no
longer be released when the patient is experiencing things that would normally cause them to

6

experience joy. Therefore, the patient is now searching for ways to get back to that extremely
high level of dopamine and the natural productions are completely offset, resulting in addiction.
In this experiment, the changes in the brain described above will hopefully be captured
by different neuroimaging techniques, such as an fMRI or EEG. It is important to include
neuroimaging in the healing approach for OUD patients because there is widespread heightened
neural activation due to the opioid cues that patients have (Moningka, et.al. 2018). Different
brain regions will interact with each other in a dynamic way that represents a range of complex
cognitive functions that relate to drug use, and therefore mapping these patterns can make
understanding the neural effects of OUD much easier.

Western Treatments and Patient-Centered Care (PCC)
Western traditional treatments that have been developed are universal and come in the
forms of medicines including methadone, buprenorphine-naloxone, and naltrexone (Johns
Hopkins University, 2020). These medicines can be classified as either agonist or antagonist
medicines. Agonists occupy an opioid receptor in the brain thereby minimizing withdrawals,
pain, cravings, and substantially decreasing a patient’s chance of relapse. Antagonists block the
opioid receptors and essentially prevent patients from receiving the mind-altering effects or
“highs” that illicit drugs can bring (Indian Health Service, 2020). These medicines are often
paired with counseling and behavioral therapies and hospital stays or visits. Some of the methods
of counseling for opioid use disorder (OUD) include motivational interviewing and behavioral
interventions, which directly attack the effects that OUD can have on personality dissolution and
the lack of sense of self (Providers Clinical Support System, 2020).
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Patient Centered Care (PCC) is an approach used in different healthcare settings in order
to include the patients, healthcare providers, and families in the treatment process, rather than the
process just being one-sided. The unique needs of the patient are addressed in the process and
three main guidelines are also followed to integrate the patient into the PCC system (figure 2).
Additionally, PCC allows there to be shared power and responsibility, and a collaborative care
and shared decision making (Marchand, et.al, 2020). A more robust description and guidelines of
PCC can be found in tables 3-6).
Traditional Western methods are extremely beneficial to patients who suffer from OUD;
the medications are a fast and effective method to attack the biological wounds that have been
created by repeated drug abuse. However, there is a lack of attention on the mental health of
addicted patients. Because of the harsh and cut-and-dry style that hospitals usually use to
approach OUD patients, these patients may be left without a sense of belonging or really an
understanding of who they are without opioids in their life.

Figure 2. Building healthcare provider relationships for patient-centered care.
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The limitations of Western medicine in other areas of substance abuse and especially
mental health disorders has the same issue of bluntness, coldness, or a cut-and-dry style that may
often cause patients to have a harder time bouncing back to a sustainable and enjoyable life. Any
type of addiction is considered a disease and furthermore a mental disorder, as a person’s
behavior and thinking are distorted and focused primarily on rewarding the brain and the new
wiring it has created due to addiction (American Psychiatric Association, 2020). The areas of the
brain affected most by substance use disorders relate directly to judgement, decision making,
learning, and memory, and thus a case is made that OUD can also be considered a mental
disorder. Healthcare in the United States is very transactional and does not necessarily have the
breadth to address community problems that may come with the individual. These additional
problems may include low socioeconomic status, past history with drug use, lower educational
achievements, or family issues, for examples. Medicines and a few motivational interviews may
help to get the patient on their feet, but where traditional methods fail is the long term and the
personal development. For example, in a study regarding injectable opioid agonist treatment
(iOAT), patients were interviewed by their caregivers, as this study was focusing on the benefits
of patient centered care and mutual trust throughout the treatment process. Initially, patients
reported trust issues and struggling to open up about their addiction problem, partially due to
experiencing discrimination in the healthcare industry (Marchand, et. al. 2020). This study
focused on the only clinic that had this sort of program going between their patients and
caregivers, which further exemplifies the wide gap that there is between OUD patients and them
finding the help that is needed to build trust and to build up their character. The gap in the
literature is what I hope my experiment will fill in.
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Culturally Specific, Holistic, and Patient-Centered Treatments
Where traditional Western methods fail, culturally specific, holistic, and patient-centered
treatments might be able to fill the gaps and in fact substantially improve an OUD patient’s
quality of life. Because these methods encompass the entire person’s being and take into
consideration cultural identities of the patient, they are more careful and well-rounded to the
point of bringing a person to self-sustainability and raising self-esteem on an everlasting
timeline. Some groups have taken it upon themselves to include culturally holistic treatment
methods that make more sense to them as a community and as people who hold ancient and
indigenous ways of knowing and healing. In order to gain a general understanding of how these
methods are applied, this section will focus on two main ethnic groups who have particularly
struggled with opioid addiction and other substance abuse, and additionally who have very deep,
pre-colonial roots and medicinal and healing methods that coincide with their cultural values.
American Indians and Alaska Natives (AI/AN) are the ethnic group with the second
highest opioid overdose mortality rate after White populations (Venner, et. al. 2018).
Additionally, heroin, opioid, and total drug use has increased in these communities since 1999
(figure 3). In primarily AI/AN communities and especially in rural areas, the opioid mortality
rate is much higher compared to White populations (figure 4). Therefore, this paper will focus
on Native American populations and their spiritual and cultural methods for addressing
addiction, while also bringing in frameworks from other ethnic groups and attempting to apply
them to the Native American ethnic group. In addition, across the literature there is a term known
as “indigenous ways of knowing,” which pull from ancient healing knowledge that indigenous
folks have had for eternity, including connections to the body, the mind, and the spirit. While
holistic healing methods would be unable to treat an OUD patient on their own, they could add
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just what is needed for a patient to really trust in their doctoral team, rebuild their character and
life, and find community, especially if a member from their community is involved.

Figure 3. Age-adjusted death rates* for total drug, opioid-involved, and heroin-involved overdose deaths
among American Indians/Alaska Natives and non-Hispanic whites — Washington, 1999–2015
,†

§

Figure 4. Opioid overdose mortality rates in the rural areas of Hennepin County, MN, and King County, WA.

The foundation of Native American traditional methods include, like was mentioned
above, reconnecting the body to the mind and the spirit. In these communities there is what is
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known as the Medicine Wheel, which depicts the four cardinal directions, north, east, south and
west, further breaking up the person into mental, physical, emotional, and spiritual (figure 5)
(McCormick, 2009). A person’s health depends on the balance of these four elements (McCabe,
2008). Aside from being a visual depiction of this balance, the Medicine Wheel also refers to
healing processes, ceremonies including sweats and sharing circles, and teachings. The most
important part of traditional indigenous healing methods is narrative and storytelling, which can
be found in other cultures as well. Elders and traditional healers often will provide insight and
tell their own stories of healing to those who are suffering, and encourage them to regain trust in
their internal dialogue “to become open to the processes of daily living, empathy, acceptance,
genuineness, challenges to accept healing forces, role modeling, safety, willingness to explore
inner and unknown experiences, ceremonies, teachings and belief in the power of the healing
spirit,” (McCabe, 2007). The self and the ego are minimized in this dialogue driven process, and
therefore blocks are removed, and the inner self is once again unlocked. Additionally, in sharing
these narratives with each other, a greater sense of community is built and connections amongst
individuals is much stronger and allows for trust and interdependence to build.
The second building block of these traditional healing methods include sweat lodges. The
doors of the sweat lodges usually have a symbol of the Medicine Wheel on them. A sweat is a
group activity led by an elder according to their specific teachings. Sweats are meant to invoke
enlightenment, clearer perceptions, deep emotions, visions, and paths towards growth or ways
out of difficult situations (McCabe 2008).
Within a sweat, a person is meant to get more in touch with themselves and build
confidence, by shutting out the outside world and other distracting sensory stimuli so that a
person can connect with the flow of energy and spirit, pushing out anxieties or negative thoughts.
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These methods are widespread throughout many indigenous groups and have maintained a
cultural foundation against colonization and oppression.
Another prominent group in the United States that particularly struggles with
substance abuse is Mexican folks and Mexican Americans. But in contrast, the cultural heritage
and lineage that precedes modern peoples in this ethnic group is so vast and has been using
culturally traditional healing methods for upwards of 400 years (Sorrel, 2020). Mexican
Traditional Medicine (MTM) are classified as a whole health or medical system, meaning

Figure 5. Native American Indigenous Medicine Circle. Denoted by four colors, the four cardinal directions,
and symbolism associated with those identifiers. Adapted from an article, “Medicine Wheels: A Mystery in
Stone,” written by J. Rod Vickers [86].Marshet al. Harm Reduction Journal (2015) 12:14 Page 7 of 12

includes many different aspects of care including nutrition, herbal products, physical movement
activities, and spiritual and mental activities. Treatments are highly rooted in interpersonal
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relationships and community building, and the current model for MTM includes a hierarchy of
lay healers including yerbero/as, sobador/as, parteras, abuelas, and finally the highest ranking
curandero, who deals with the entire aspect of a patient’s illness, including rebuilding bonds
with the patient’s family and community.
At the lowest level, abuelas, which directly translates to grandmothers, usually act as a
counselor and the first tier that someone may go to for common illnesses or issues within the
household. They are most easily accessible and can act as a medical liaison to assist patients in
getting the care they need and help break down the stigma as a trusted member of the
community. Yerbero/as are members of the community who have an extensive knowledge
around sacred herbs, plants, seeds, etc., that can be combined to create ailments for many
different problems, ranging from gastrointestinal issues to cancer. Sobador/as are particularly
known for their knowledge of the body and their ability to rejuvenate patients with their hands,
focusing on massaging and pressure points. Parteras are specifically trained to help with birthing
and any issues that arise with pregnancy. And finally, curanderos encompass a wide range of
medicinal knowledge and are the highest-ranking members of the MTM system. Curanderos are
also the link from the patient to the family and community, preserving and restoring balance
once a patient seeks their help (Neff, 2002). Similar to Native American methods, curanderos
will also utilize prayers, narratives and chants, and rituals.
One of the biggest assets that MTM brings to the table is reducing the stigma that
surrounds OUD in the Mexican community. Similar to mental health, seeking help for substance
abuse is often overlooked or can even be seen as a sign of weakness. MTM is similar to
American Indian indigenous methods as it intends to address the imbalance one may find in their
spirit, body, and related energies. An important aspect that is taken into consideration in the
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MTM system is the Nonlinear Dynamical System (NDS) of Healing. Most importantly, NDS
takes into account that healing for everyone is not always beginning in one spot and ending in
another and will most likely follow many different paths over a long period of time. The goal
with NDS within MTM is for the person to heal more holistically and improve the patient’s
quality of life in all aspects (Sorrell, 2020). By integrating MTM practices with Western
methods, general participation in healthcare could possibly increase for Mexican people and
Mexican Americans.
Holistic methods for drug addiction and abuse prove to be less effective than traditional
methods such as medicines, inpatient care and therapy, but can provide a more encompassing
approach than just these traditional methods alone. The importance of accompanying traditional
or Western healing methods with holistic methods and patient centered care can mean all of the
difference for someone recovering from a substance abuse disorder. My goal is to demonstrate
how the combination of the two make a winning combination for people suffering from
substance abuse.
OUD patients who receive a combination of Western traditional methods and culturally
holistic methods will have lower stress levels, higher retention rates, and a more improved sense
of identity and belonging than those who undergo Western traditional methods alone.

Purpose and Predictions
This study will address how adding holistic, cultural, and patient-centered methods can
benefit opioid users by increasing their self-esteem, reintegrating them back into normal life and
with their families, and generally addressing their issues with a more well-rounded approach.
Since the opioid epidemic harms the lives of all groups of people, the study proposed below will
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take into account different personal identifiers. These identifiers will be useful during the
experiment when deciding how to culturally address the addiction with specific holistic methods.
What I intend to do in my experiment is incorporate methods from the American Indian
practices and include them in MTM practices and vice versa, combining both with Western
medicine. By combining two indigenous ways of knowing with two ethnic groups that
particularly struggle with OUD, I am hoping to create an intersection that is the most helpful.
Alternative hypotheses will address issues associated with the resistance to use practices from
other cultures into healing rituals.
Through personalized interviewing, I believe that patients who receive the combination
will have answers that address more aspects of their personal life and express reintegration into
their families and outside world. Additionally, a chosen elder or member of their community
could be assigned to monitor them in social and professional settings to comment on their
progress as well, since they will have had to do with the holistic method applied. Questions on
the survey will address self-esteem, family questions, and questions that address the meaning or
importance of their new life.
The experiment will consist of two groups, one which will only be receiving MAT and
the second which will be receiving both MAT and culturally holistic treatment methods. Each
group will consist of 45 OUD patients each, for a total of 90 subjects. A total of six methods will
be used to measure and compare the results between each group.
The first measure that will be used is a simple sobriety retention measure, in order to map
how sober each group is throughout the experiment. This measure is significant because it
highlights the success rate of the treatments. I predict that both groups will have a similar curve,
yet group 2 might have higher retention rates due to a deeper commitment to the treatments.
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The second measure that will be utilized is familial reintegration level, which will be
measured using the Family Environmental Scale (FES). This measure will be one of the most
important as it measures many aspects of a family lifestyle and how the patient will adapt over
time. Additionally, patients in both groups will be given writing prompts to record their
development over the experimental period. It is important to stimulate a patient’s introspective
and reflective abilities in such a transformative process such as getting clean. These two tests
will really measure if the person has had a significant change in lifestyle.
Biologically, through a blood sample I also predict that patients who receive all of the
treatment methods will show the most decreased levels of cortisol. A stress response in opioid
users is very common, especially during withdrawals or at the beginning of their journey towards
ending addiction. Those who are only receiving medicinal and Western methods will also see a
decrease in cortisol, but not at the same levels. Additionally, a weekly swab will be implemented
to test for the drug, and finally neuroimaging methods of fMRI and EEG will be used to test the
brain activity in the patients as well. Brain studies are particularly useful because they measure
different patterns of activities of patients that may illicit these changed behaviors. Neuroimaging
is one of the most important measures in this study.
My ultimate goal is to demonstrate that supplementing western methods with culturally
specific holistic methods will fill in the gaps where patients are missing a community aspect and
individual, personal development. I predict that the group who receives a combination of
traditional medicinal applications of healing, holistic methods, and patient centered care
combined will see the most prominent improvement in health and beginning of remission. As of
now, there is no experiment that has analyzed the combined effects of medically assisted
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treatments and holistic methods, therefore this novel proposal would be extremely useful to the
development of treatment for OUD.

Materials, Methods, Proposal
This study will be approved by the Institutional Review Board at Claremont McKenna
College in accordance with the currently applicable U.S. Public Health Service guidelines. All
participants will provide written informed consent for all research testing.
My intention for this experimental protocol is to fill in the gaps where other studies have
not yet ventured. While no study yet has studied combined effects of holistic and western
treatment methods, there have been a few literature reviews and meetings about how Native
American folks particularly would like to see medical assisted treatment (MAT) integrated with
their community holistic methods (Venner, et. al., 2018). Ambitiously, I would also hope to try
and integrate Mexican Traditional Methods within the framework of American Native groups
and vice versa as well, doing my best to parallel the members of the community.
Survival curves will be utilized in this study as well as a system of checkpoints filled in
by the patients’ mentors and community members, in addition to cortisol testing and swabs in
order to see if opioids are still present in the patient, from beginning to end of the study. The
community involvement and activities will be measured by a graded checklist, in addition to 3
interviews with the same questions at the beginning of the study, halfway through treatment, and
at the end of treatment.
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Subjects and Recruitment
To best demonstrate, this experiment will consist of 90 OUD patients of Mexican
heritage or of Native American/Indigenous heritage. 45 patients will receive Western medicines
and PCC only (group 1), and 45 will receive western medicines in addition to the combination of
cultural and holistic methods (group 2). Measurements for gender, age, race, and ethnicity will
obviously be utilized. It will also be important to record if any of the OUD patients have mental
health comorbidities.
To recruit these patients, I will travel to areas in the country with the highest density of
both populations and approach patients with a new model of treatment that will take their
community upbringings into account, and provide a full informational that would show the
benefits of medicinal assisted treatment and holistic methods as well. The draw would hopefully
come from that communal aspect. Patients might be able to be found in addiction clinics or from
lists of current patients that have suffered from OUD. The patients can range from all age groups
and gender identities.
In order to protect the identity of the patients, each will be assigned a patient number via
code to which the key will be secured in an external location.

Initial Measurements
Initial measurements for each patient will begin with gender, age, race, ethnicity, socioeconomic status (income levels), severity and type of opioid use, and age of first use of opioids.
Further biological measurements will include a blood test for initial measurements of cortisol,
weight, and height, as weight will also be tracked throughout the study. Typical symptoms of
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OUD will also be screened for, which includes searching for track marks on the inner arm,
pinpoint pupils, drowsiness, and slurred speech. These symptoms indicate opioid intoxication.
Patients will also undergo emotional and psychiatric testing by medically licensed nurses,
therapists, and psychologists, for an initial measure on their mental health and emotional and
spiritual state. Another label for this method is Patient-Centered Care. This routine will be
conducted for subjects under both categories, since therapy and psychology are emblematic of
western treatment methods.
Patients who are in the category of receiving western traditional methods and culturally
holistic methods will undergo an examination by a trusted leader of their communities; for
Native American and Alaska Native patients, a spiritual elder will conduct the test guided by the
medicine circle. For Mexican and Mexican American participants, a curandero along with their
primary abuela will conduct the examination.

Table 1. Sample biological checklist for each patient
Gender

Age

Race

Ethnicity

Patient A

F

18

Black

Patient X

M

25

White

Patient Y

F

50

Brown

Native
American
Mexican
American
Mexican

Patient Z

NonBinary
(NB)

34

Brown

Mixed
(White and
Native
American)

SES/Income Initial
Cortisol
(mcg/dL);
time of day
40,000
15; 7am

Height
(inches)

Weight
(lbs)

68

140

23,000

7; 7am

67

152

30,000

12; 7am

62

125

60,000

3; 4pm

70

170
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Table 2. Sample opioid use checklist and severity levels
Age of First Use

Type of Opioid(s)

Severity
(1-10)

Patient A

Intoxication
Upon Arrival
Yes/No
Y

14

Heroin, Fentanyl

8

Patient X

N

19

Prescription

4

Patient Y

Y

21

Prescription

6

Patient Z

Y

30

Heroin

7

Patient Centered Care Tables
Modeled off of a study done in 2019 by Marchand, et.al. Adjustments were made as this was
based on a smoking study.
Table 3. Directed content analysis of the defining characteristics of holistic care (holistic within
a Westernized approach in a hospital setting)
Defining Characteristics

Representative example from healthcare worker

Integrated delivery of physical health,
mental health or psychosocial supports
within addiction treatment setting

“Other interventions designed to improve the potential for a successful outcome
included educational sessions about the harmful effects of [opioids] and the
benefits of stopping, stress management, the value of developing a support
network, improving nutrition and avoiding significant weight gain after
stopping [using], the importance of a safe and regular exercise program, and
understanding the potential role of spirituality.”

Coordination of health or psychosocial
services as part of addiction treatment

“If a woman was involved with many service providers, the ICF [Integrated
Care Facilitator], with the woman’s permission, would maintain contact with
those providers to ensure that all providers understood her needs in a similar
way and that services were coordinated.”

Adapting a gender-responsive
approach to the delivery of health,
substance use, and psychosocial
treatment

“It allows clinicians to treat addiction as the primary problem while also
addressing the complexity of issues that women bring to treatment: genetic
predispositions, health consequences, shame, isolation, histories of abuse, or a
combination of these.”

Integrated delivery of addiction
treatment as part of a primary care or
hospital setting for other health or
psychosocial needs

“[MAT; Medical Assisted Therapy] was available to participants at no cost
during hospitalization. A variety of group meetings were held according to a
preset time schedule which was announced at the unit. The degree to which
patients participated in the meetings differed depending on the length of their
hospital stay.

21

Table 4. Directed content analysis of the defining characteristics of shared decision-making
Defining Characteristics

Representative example from healthcare worker

Client and provider dialogue
to reach a mutual decision

“The form of MAT selected is a joint decision made by the client and advisor and is based
on the client’s individual [opioid] habits and feelings as well as any contraindications.”

Autonomous decision-making

“Participants appreciated the practitioners’ active listening skills. For example, one client
noted that her request to not use tablets or patches for smoking cessation was recognized by
the practitioners as the topic was not broached again in consultations.”

Table 5. Directed content analysis of the defining characteristics of therapeutic alliance
Defining Characteristics

Representative example from healthcare worker

Non-judgmental, respectful
and accepting

“A major theme discussed by patients was the importance of building supportive
relationships. Patients expressed a desire to work with staff who possessed qualities such as
empathy, understanding, trust, respect and expertise and described feeling accepted in these
relationships. Patients who perceived staff to be nonjudgmental in their approach described
that this reduced their feelings of shame.”

Empathy, understanding,
warmth, kindness, supportive

“The nurse engages in caring relationships with patients with the purpose of helping them to
handle a complex and intricate health problem in a dignified manner, acknowledging the
therapeutic effects of feeling being understood as a patient.”

Table 6. Directed content analysis of the defining characteristics of culturally safe care
Defining Characteristics

Representative example from healthcare worker

Adapting care plans to meet
culture-specific preferences

“Akeela House developed a model that incorporated traditional Alaska Native cultural
lifestyles into the therapeutic community treatment approach. This was termed a “Spirit
Camp Model” and consisted off our major elements: (1) spirit groups, (2) cultural awareness
activities, (3) urban orientation, and (4)individual counseling. To implement these
components, additional Alaska Native counselors were hired.”

Inquiring about health and
healing practices of the client

“The nurse engages with Charlie to prioritize his needs. He/she discusses his living situation
and how he sees the future. The nurse does an assessment in keeping with the principles of
cultural safety and cultural competence–he/she begins by asking Charlie if there is anything
that he/she should know about him (e.g. beliefs about health and healing practices) to assist
with his treatment plan and before making referrals etc.”

Reflecting on personal beliefs,
assumptions and biases

“The concept of cultural safety takes critical inquiry a step further by requiring nurses to
reflect on issues of racialization, institutionalized discrimination, culturalism, and health and
health-care inequities.”
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To further clarify, patients who are receiving the Western methods of treatment will
undergo MAT, meaning they would be administered a drug of their choosing between
methadone, buprenorphine-naloxone, and naltrexone, and simultaneously receive PCC from their
doctors, nurses, therapists, and psychologists, outlined in tables 3-6.

Experiment
Hopefully, after approval from the IRB for all of the neuroimaging, blood and saliva
tests, and questionnaires, the experiment will last 6 months, as this is the time period that OUD
patients mostly undergo MAT (Biondi, et.al. 2020). This time frame would allow patients to
undergo a full transformation whether they are receiving culturally holistic methods or not.
When patients arrive to the testing facilities, they will be routinely swabbed for opioid
presence. Patients will receive treatments once a week. After this, they will receive their chosen
agonist or antagonist medication, be checked upon by a healthcare professional who follows
PCC guidelines; these conversations will have notes taken upon them by the healthcare
professionals, like in tables 3-6.
If the patient is in Group 2, they will be accompanied by their chosen sponsor or mentor
from their cultural affiliation. This sponsor will have a journal where they take notes, monitor the
patients’ emotions and mental headspace, and track their spiritual progress. In addition, group 2
patients will have a secondary session per week where they embark on a healing practice with
their mentor, community, or family.
In these weekly or twice per week sessions, patients will have their cortisol levels
measured via a urinary sample taken in the morning. Once a month, a therapist will check in with
them and track their progress as well. Additionally, both groups of patients will have a journal
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where they respond to the same prompts, and answers will between groups will be compared at
the end.
The records kept by the psychiatrists, therapists, and healthcare providers will be scanned
into an electronic system and the paper files will be stored under the patient’s numerical code file
in the external location. Our team would have access to the scanned files in addition to the
healthcare providers, to manage progress and data entry.

Traditional Western Methods; Medical Assisted Treatment (MAT) and PCC
Patient Centered Care
All patients in group 1 will be treated by specialists who understand PCC and adopt the
methods of holistic care, shared decision making, therapeutic alliance, and culturally safe care.
These practitioners will take note of the conversations they have with patients, focused on trust
level, efficacy, and perceived mental and emotional progress based on the patients’ answers.
Additionally, patients in Group 1 will have a sponsor who will be taking notes on their progress
and ranking the patients’ headway. This progress form will be identical to the mentors’ progress
forms in Group 2.

Buprenorphine
Administers of buprenorphine will need to undergo buprenorphine waiver training and
obtain a waiver. This drug can be prescribed in tablet, film, buccal film, implants, or injection
form. Buprenorphine works as an opioid partial agonist and can cause euphoria or respiratory
depression. Overall, buprenorphine diminishes the physical dependency to opioids, such as
withdrawal symptoms or cravings (SAMHSA, 2020). In order for a patient to be treated with
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buprenorphine, they must abstain from taking opioids 12-24 hours prior to receiving the
treatment. Once the patient substantially reduces opioid use, the dosage may be decreased.

Methadone
For this medication, administers will need to undergo a SAMHSA (Substance Abuse and
Mental Health Services Administration) certified treatment program where they will become
certified in the Opioid Treatment Program (OTP). Methadone, in contrast to buprenorphine, is a
long-lasting opioid agonist, which reduces craving and blocks the effects of opioid usage. This
treatment is taken daily and comes in forms of liquid, powder, and diskette form. (SAMHSA,
2020).

Naltrexone
Also known as intramuscular extended release naltrexone, this medication can be
prescribed and administered by anyone who is legally able to give medicine. For treating OUD,
this medicine is only available in injectable form, which is injected once a month. Naltrexone
works to block the euphoric and sedative symptoms that come with ingesting opioids by binding
to and blocking opioid receptors in the brain. Patients who elect this option must wait 7 days
after using a short-lasting opioid or 10 to 14 days after a long-lasting opioid before accepting the
medicine (SAMHSA, 2020).

MAT Plus Culturally Holistic Methods
In addition to receiving their elected medicine, patients in Group 2 will undergo a cultural
healing process which has integrated methods from American Indigenous practices and Mexican
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Traditional Healing methods. As mentioned above, each patient in Group 2 will have a mentor
who is tracking their healing process and additionally guiding them to cultural healing activities
that will be a part of the process. Additionally, Group 2 will fill out the progress form which is
identical to Group 1’s progress from.
The experiment is lasting 6 months which allows for about 2 cultural healing sessions per
month, or biweekly, adding up to 12 sessions total. Luckily, there are some intersections between
Native American and Mexican cultures, so the crossover should not be too difficult.

Group 2 Holistic Healing Schedule
Activities adapted from a literature review done by Rowan, et.al. in 2014.
Session 1: Goal Setting
Participants will meet with their mentor, which will be the equivalent of an abuela or
trusted community mentor, and their families to go over and create goals for the patient and their
healing process.
Session 2: Foundations of Cultural Healing
Participants will be introduced to the Medicine Wheel by a Native American elder and
explained its healing and cultural significance. A yerbero will also be present to put forth the
importance of being connected to the earth and going through various types of plants that can
ease muscle pain and anxiety. These two members together will explain the importance of
aligning the body, mind, spirit, and energies.
Session 3: Land Base Activities
Participants will travel to a sacred location where the healing properties of the land have
been conferment by community members. Here they will walk in solitude, walk together with
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their mentors, and have a Medicine Wheel to reference healing directions while they walk. In
addition, participants will have a chance to help build a garden for the community.
Session 4: Storytelling and Narrative
Now that participants understand the general flow of meetings, they will participate in a
story telling session with other participants from Group 2, their mentors, and lead community
members. Storytelling and narrative are prominent in both cultures and is usually led by the
elders who have had stories passed down through their lifetimes.
Session 5: Talking Circle
This talking circle will have been primed by the previous session and will allow
participants to share their progress with their peers and have a general discussion about health
and energy flow with their mentors.
Session 6 & Midpoint Evaluation: Sweat Lodge and Temazcal
This session is the culmination of the first half of the holistic treatment. In Native
American cultures there are sweats which take place in a sweat lodge, and in Mexican culture,
with a slight variation of preparation, there is a temazcal. These sweats are seen as medicinal and
emotional treatments. The sweat will be followed by a midpoint check in with the mentors.
Session 7: Art Creation
Participants will be able to engage in beadmaking, rug weaving, and basket weaving.
Beadmaking is popular in both Mexican and Native American cultures, while rug weaving is
very prominent in Mexican cultures, and basket weaving in Native American cultures (citations
needed). The opportunity to learn from artists and to engage in this form of therapy will be very
renewing for the participants
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Session 8: Cultural Instruments; Drums and Trumpets
Drums and trumpets are iconic instruments to the Native American community and
Mexican community, respectively, and this will be a really immersive and hands-on learning
experience for the participants.
Session 9: Land Base Activities: Swimming/Cleansing
Swimming in a spring-fed pond will reenergize the participants and provide a moment to
be pensive, introspective, and reevaluate their position within nature and the earth. Water is
understood to have healing and cleansing properties, explained to the participants by the
yerberos and elders.
Session 10: Storytelling and Narrative II
At this point in the trial, it is expected that members of Group 2 will have a lot to share,
and hopefully many stories to tell. The stories at this point will be more personal, deep, and
metaphorical, led once again by the mentors and community members.
Session 11: Sweat Lodge and Temazcal II
Nearing an end, the participants will engage in their penultimate activity, which will be
another sweat session for a final cleansing. In this session, chants and grunting will be led by the
sweat organizer which is meant to be a cathartic release.
Session 12 & Final Evaluation: Welcome Home Celebration
Finally, all members of Group 2 will cook a traditional dish with their families to bring to
the Welcome Home celebration, which is mean to celebrate how far each of them has come in
their healing process. Traditional music and dances will be performed by both cultural groups,
and all members engaged in the trial will be invited. Additionally, the final evaluation will be
handed in by each participant’s mentor.
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Writing Prompts for Group 1 and Group 2
In order to compare the personal journeys of the patients in both groups and compare
their answers, they will both respond to a total of six writing prompts, one for each month of the
treatment that they’re in.

1. What is your biggest motivation right now to get sober and stay sober? List three of your
top reasons.
2. What are some concerns that you hope healthcare workers and others involved in your
care should know about? What do you feel is necessary to address in order to receive the
best care?
3. Has your whole personhood been addressed during your treatment, or do you feel as if
you are another statistic on a page?
4. Do you feel connected to your identity, energy, mind, and spirit? Do you feel any
misalignments or alignments, or are you having any realizations? Have you regained a
sense of self?
5. What has helped you most so for in overcoming the obstacles that came with your
disorder? What are some challenges you still face now?
6. How would you compare your connection with yourself, your family, friends, and with
your immediate community before and after your treatment? What are some of the
biggest differences between then and now?

Expected Results
Sobriety Retention
The first variable measured was the survivor rate for participants who are not using
opioids anymore. This test was done using swabs every week.
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Figure 6. Sobriety retention between treatment groups.

Familial Re-Integration
Using the Family Environment Scale (FES), form R (which measures the current family
environment), the 90-item scale presented us with results for Group 1 and Group 2 before and
after their treatments. The control group is represented by normative data.
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Group 2
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Figure 7. Mean values on Family Environmental Scale’s subscales in families with a member with OUD and
control prior to treatment.
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Figure 8. Mean values on Family Environmental Scale’s subscales in families with a member with OUD and
control following treatment.

Significant Change in Lifestyle
This section will be dictated by the progress reports that will be turned in by Group 1’s
sponsors and Group 2’s mentors. These will be filled out thrice, once at the beginning, halfway
point, and end of treatment. The mentors will have to rank their patients’ advancements and
fallbacks on a scale of 1-10, 1 being the lowest and 10 being the highest.

Table 7. Sample progress report for mentors.

Patient Edward Gonzales, Group 2. Midpoint Evaluation.
PROMPT
1. The patient is enthusiastic about
participating with their correspondents.
2. The patient has a good attitude or is
cooperative when receiving treatments.
3. When engaging in conversation, the patient
is introspective about their healing journey.
4.The patient has reduced their obsession
with opioids; they rarely talk about them.

RANKING (1-10)
6.5
5
3
8
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5. The patient shows care for their loved ones,
alleviates guilt or shows remorse.
6. The patient has expressed interest in
physical activity, hobbies, or art activities.
7. The patient is building a strong
relationship with you (their sponsor or
mentor).
8. The patient is interested in their treatment
and is curious about medical jargon, how
their treatment works, etc.
9. The patient shows their appreciation to
everyone involved in their treatment.
10. The patient has regained their sense of
belonging and self.

6.5
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9

4

9
5

10
9
8

Mean Ranking
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Figure 9. Mean rankings of participants (n=45) for each question in the progress report for Group 1 and
Group 2 at the midpoint of treatment.
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Figure 9. Mean rankings of participants (n=45) for each question in the progress report for Group 1 and
Group 2 at the end of treatment.

Writing Prompt Comparisons
The writings were scrutinized by mentors and sponsors alike. Testimonials will be
recorded from the participants in each group. Answers will be compared between the groups to
determine different levels of self-reflection, realization, and personal development.

Cortisol Levels
Cortisol is an important factor to measure as it has many functions in the body, including
regulating our metabolism, controlling blood sugar levels, reducing inflammation, and assisting
with memory formulation (Hormone Health Network, 2018). Cortisol is known as the “stress
hormone” and is actually a steroid hormone that is made in the adrenal glands. Cortisol receptors
are found in a majority of the cells of the body. The HPA axis, which is a combination of the
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hypothalamus, pituitary glands, and adrenal glands, controls the secretion of cortisol in the body
(Hormone Health Network, 2018).
An adverse effect of using opioids is that it may cause opioid-induced adrenal
insufficiency (OIAI), or exert tonic inhibition (Donegan, 2018), which is essentially the
suppression of the HPA axis. Approximately 9%-29% of OUD patients encounter OIAI, and
most of those in this category are long time opiate users (Tucker, 2019). Therefore, in this
section of the results we should be expecting lower levels than the control, which is a healthy
patient. Upon cessation of using opioids, though, there is a spike or elevated response (Kakko,
et.al. 2019), which is predicted in the second urine sample. The patient will urinate into a
container biweekly between 6 and 8am, when cortisol levels are the highest. The normal cortisol
range in people 18 and older ranges between 3.5 mcg/24hrs and 45 mcg/24hrs (Mayo Clinic,
2020).
40
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Figure 10. Mean urinary cortisol levels (mcg/24hrs) taken biweekly over the course of treatment.
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Neuroimaging: fMRI and EEG
This section will be modeled based on a study done in 2019 by Stewart, et.al. (2019).
Their model was conducted within the Three Stage Model of Addiction (Koob, 2016), in which
the three stages are (1) Binge/Intoxication (2) Negative Reinforcement and (3) Anticipation/
Preoccupation. The three stages are linked to abnormal patterns in the brain regions that regard
reward processing in the ventral striatum (VS), cognitive control within the frontocingulate
regions including inferior frontal gyrus (IFG) and anterior cingulate cortex (ACC), aversive
emotional states in the amygdala (AMG) and interoception or the awareness of the internal body
state in the insula (INS) (Stewart, et.al. 2019).
Beginning with fMRI testing, a resting state fMRI to be specific, it was found that
patients with OUD have a weak frontocingulate functional activity with subcortical regions, but a
strong functional connectivity within subcortical regions such as in the striatum and the AMG. In
line with stage 3, or the Anticipation/Preoccupation stage, data from multiple fMRI studies
concluded that patients with OUD also experience weakened INS connectivity to IFG, striatum,
and AMG (figure 11). For my study, I would expect to see these lower connectivity levels in the
beginning of the treatment, and heightened connectivity throughout and towards the end of the
experiment.
An EEG, on the other hand, is a continuous recording of ongoing brain electrical activity.
Measurements of voltages in an EEG are usually separated into specific frequency bands that are
associated with different mental processes. One band that will be focused on is the beta band,
and the most consistent finding is that patients with OUD exhibit greater beta power than healthy
individuals (figure 12). These increases could be related to a decreased need for future motor
actions, classifying opioid users as having reduced behavioral activation (Stewart, et.al. 2019).
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Therefore, this study would predict that patients in Group 2 would have a stronger INS
connectivity at the end of the treatment, and less prominent beta band power and increased need
for future motor actions. Neuroimaging is extremely significant for understanding OUD patients
as it distinctly maps out specifically where in the brain different neuronal patterns can be found
and how they differ from normal patterns.

Figure 11. Regions of interest and blood-oxygen-level-dependent (BOLD) results from an fMRI. Based on a
task-based fMRI with drug cues shown.
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Figure 12. Brain regions and processes that potentially map onto Negative Reinforcement and
Anticipation/Preoccupation stages of the Three-Stage Model of Addiction. EEG, electroencephalography;
ERN, error related negativity.
Table 8. Key psychological and neurobiological processes reflected in the Three-Stage Model of Addiction.
Frontiers in Psychiatry, 2019.

Binge/Intoxication

Negative Reinforcement

Anticipation/Preoccupation

 Ventral striatum dopamine
release

 Hypothalamic-pituitaryadrenal axis stress

 Basal ganglia driving drug
craving and urges

 Glutamine and dopamine
changes in striatal connections
between the prefrontal cortex,
basal ganglia, and amygdala

 corticotropin releasing factor
in amygdala

 Prefrontal cortex inhibiting
distractors

 Striatal dopamine, serotonin,
and opioid responding

 Incentive salience linked to
insula and glutamate
prefrontal-ventral striatum
signals

 Natural rewards
fMRI results
AMG-VS connectivity

fMRI results
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AMG to negative stimuli and
drug cues within context of
recent drug use and withdrawal
 AMG to negative stimuli
AMG, DS, and VS to drug
cues with naltrexone

 VS to drug cues predicts
relapse
PFC to natural rewards

EEG
 beta power and hyper
connectivity

Discussion
As the opioid crisis continues to be a huge overarching problem for so many people in the
United States, this study is hoping to not only contribute to the current studies of medical
assisted treatment and patient-centered care, but to fill the gap in the literature which leaves out
the possibilities of incorporating culturally holistic care as well. Opioid addiction gravely
impacts peoples’ lives not only biologically, but also socially and personally with regards to
losing a sense of self or a sense of belonging. For this reason, turning to ancient healing practices
that center around indigenous knowledge and methods relating to the earth’s energy, general
spirituality, and connections to nature and the greater cultural community. While MAT has been
proven to be a strong method to help OUD patients recover from their addiction, adding these
holistic methods will allow the patient to heal in ways that western medicine is unable to reach.
Therefore, in combining these two methods, the pairing will create an unbeatable treatment for
patients with OUD.
In order to study the gap that lies between MAT and holistic methods, a number of
qualitative and quantitative methods will be used pertaining to a patients biological functioning
in addition to emotional and personal development. The main models that will be used to study
these additional healing factors are sobriety retention using survival curves, familial re-
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integration using the Family Environment Scale (FES), a significant change in lifestyle
evaluation filled out by the patients’ mentors and sponsors, journal entry comparisons, urinary
cortisol levels, and finally, neuroimaging. In the case that this study will be approved by the IRB,
it would be very encompassing given that there are so many measurements used, which only
strengthens the case that conducting a study like this would greatly benefit all communities with
cultural roots and heritages.
The most important results in this study will include the progress made by both groups in
according to the FES scale and the results found by the fMRI and the EEG. These robust
methods of testing how families will integrate following treatment and the rigorous use of
neuroimaging will provide promising results that Group 2’s treatment presides over the current
and only method of MAT. At the end of treatment, the results from the FES will show that Group
2’s mean scores improved exponentially from the beginning of the trial, and most specifically
much higher than Group 1’s progression in the Conflict, Intellectual-Cultural Orientation, and
Moral-Religious orientation groups. Mean scores all rose in these groups which is no doubt
attributed to the culturally holistic methods that were conducted in order to stimulate interest in
personal development with regards to energy and spirituality, tighter affiliation and connection to
their home culture, and essentially reducing conflict between themselves and their family and
immediate community (figure 8). These results are consistent with the literature that supports an
integration of indigenous ways of knowing and MAT. In a study done by Venner, et.al. (2018),
as they discuss how members of the Native American community laugh at the thought of only
using MAT to treat their community. Additionally, the neuroimaging will show prominent
results throughout the different stages of addiction. As discussed in the introduction, when
someone is intoxicated their dopamine and glutamine levels spike, this causes for the
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reconfiguring of the striatal connections between the prefrontal cortex, basal ganglia, and
amygdala. Additionally, in the second phase of Negative Reinforcement, we can see from the
fMRI that connectivity between the amygdala and the ventral striatum is increased (table 8),
representing the increased activity in reward pathways due to intoxication. The most significant
result will be the increased beta band power and hyper connectivity found in the EEG (figure
12).
Other results, while encouraging, are less rigorous but supplementary to the predictions
made about the study. The sobriety retention survival curve is measuring the fraction of patients
in each group that remained sober throughout the entirety of the experiment. As predicted, Group
2 will have consistently higher ratios of patients who remained sober throughout the 6 months,
and by June, or the last month of treatment, 100% of OUD patients were sober (figure 6). As for
comparisons of the journal entries, I predict that patients will their personal growth journey in the
latter half of their journal entries, as shown by writings being very introspective and reflecting on
regrets, but most importantly having sights set on the future. Group 1’s entries did not entirely
lack references to personal growth, but this was not the main focus whatsoever. In addition, the
cortisol levels to be found in both groups were quite similar (figure 10). Finally, the evaluations
from the mentors will show much higher mean scores in Group 2 for every question except one.
While the rankings are subjective since they were taken by another person, the interpersonal
skills and relationships of someone with OUD are harshly impacted and with these results show
how effective holistic methods can be.
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Limitations
The most important aspect to acknowledge as a limitation is respecting the use of ancient,
holy, and precious methods of knowledge from both the Native American and Mexican cultures.
It is ambitious and almost out of a scientist’s jurisdiction to decide whether members of separate
cultures will feel comfortable engaging in activities that are completely foreign to them for the
purpose of collecting data. It may also be arrogant to assume that these two cultures would give
up their knowledge and practices so readily in order to be used for a scientific study which
follows Western practical methods and construction. While these communities undoubtedly want
to help their members with OUD, scientists with a novel study like this one may be seen as
saviors, colonizing their sacred practices.
Another huge limitation for this study was the lack of literature, or absolute absence of
any literature that compares MAT and evidence-based treatments with any holistic, cultural,
and/or indigenous methods. This is most likely due to the fact that these holistic methods have
never been taken seriously enough to treat a disorder as strong and intense as opioid use. The
chemical alterations and effects of opiates might be considered too strong to address without the
use of medication or hospitalization.
Because of these limitations, it may be difficult to generalize the data I have projected.
Considering the limitations, we would likely have to account for participants dropping the study
or disagreeing morally with the combination of two cultural practices.
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Conclusions and Future Directions
The projected results are extremely promising of future studies that continue to combine
MAT and culturally holistic methods. The results suggest that future studies for patients with
OUD should include at least one cultural activity, holistic method related to their culture, and
definitely at least patient-centered care. Further research on holistic methods alone with different
substance use disorders might be helpful as well and provide a groundwork for studies including
holistic methods in the future. It would be necessary to have community elders and mentors
present and preferably a part of the research team to make sure methods are accurate and
appropriate.
It would be very beneficial to the many groups that are dedicated to studying and trying
to resolve the opioid crisis to continue to implement different methods in addition to medical
assisted treatment. It is obvious that MAT is one of the best methods to use for patients with
OUD, and this study further concludes its strengths. But with this new information on
incorporating a patient’s identity and culture in order to improve their socialization after seeking
out treatment for their addiction issues, it could be the turning point that was needed to address
this huge crisis in a more encompassing way.
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